Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Belgian cancer treatment equipment maker IBA to install compact proton therapy centers in UK
Thursday, June 25, 2015Belgian cancer treatment equipment maker IBA said on Thursday it had signed agreements to install three compact proton therapy centers in Britain The company said the deals containing immediate down payments included year maintenance contracts The...
Rheumatoid arthritis drug tofacitinib citrate breakthrough treatment for leucoderma
Thursday, June 25, 2015In a first a medication for treating rheumatoid arthritis has restored skin colour in a patient suffering from vitiligo The results of the study were published on June in the journal JAMA Dermatology Leucoderma is a condition that causes skin to lo...
Soon-Shiong’s NantCell acquires Italian Stem Cell Firm VivaBioCell
Wednesday, June 24, 2015NantCell the immunooncology subsidiary of billionaire Patrick SoonShiongs growing NantWorks health care technology empire has acquired tissue and stem cell engineering firm VivaBioCell Terms of the deal were not disclosed Udine Italybased VivaBioCel...
Drug firm Jubilant Life Sciences gets USFDA nod for generic levofloxacin tablets
Wednesday, June 24, 2015Drug firm Jubilant Life Sciences has received approval from the US health regulator to market generic levofloxacin tablets used to treat various infections including pneumonia The company has received approval from the US Food and Drug Administratio...
Pfizer to acquire Two Meningitis Vaccines from GlaxoSmithKline for $130 million
Tuesday, June 23, 2015Pfizer Inc has agreed two acquire meningitis vaccines from GlaxoSmithKline PLC for about million a move to expand its global reach in preventing meningococcal disease New Yorkbased Pfizer said it would buy Nimenrix and Mencevax both singledose meni...
Kite Pharma, Bluebird collaborate on cancer T-cell therapies
Tuesday, June 23, 2015Cancer drug developers Kite Pharma Inc and Bluebird Bio Inc said they would partner to develop and market Tcell therapies for HPVassociated cancers Tcell receptors are a class of compounds that make it easier for the bodys immune cells to mainly ide...
FDA approves Medicines Co's blood clot preventer Cangrelor after a decade involving $200 million investment
Tuesday, June 23, 2015The US Food and Drug Administration on Monday approved Medicines Cos blood clot preventer Cangrelor which has faced multiple setbacks since it first entered latestage studies close to a decade back Cangrelor also known as Kengreal is an intravenous...
DBV Technologies SA confirms initiation of Viaskin Peanut global phase III trial
Tuesday, June 23, 2015DBV Technologies SA Confirms planned initiation of Viaskin peanut global phase III clinical trial in children following endofphase II meeting with FDA and PIP approval by EMA Based on regulatory consultations company plans to initiate a global phas...
European private equity fund CVC, Singapore's Temasek to buy generics firm Alvogen
Monday, June 22, 2015European private equity fund CVC and Singaporean sovereign wealth fund Temasek TEMUL are to buy a controlling stake in the pharmaceutical firm Alvogen its chairman and chief executive said Robert Wessman former CEO of Actavis founded the New Jerseyb...
Biofrontera Pharma completes final steps for FDA new drug application
Monday, June 22, 2015Biofrontera AG Completes final steps ahead of FDA new drug application in the USA Drug Master File for active substance ALA acknowledged by FDA Biofrontera Pharma GmbH registered as medical device manufacturer Successful migration to a pharmac
